Pyxis Oncology Inc. News
Latest updates and market news for PYXS
3 news
Dec 13 - Dec 19, 2025
Page 1
MT Newswires
Investors Await Key Inflation, Employment Data as US Futures Rise Thursday Pre-Bell
➖
AI Sentiment
Neutral
5/10
GlobeNewswire
Pyxis Oncology Announces Positive Preliminary Phase 1 Data for Micvotabart Pelidotin (MICVO) in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
📈
AI Sentiment
Highly Positive
8/10
Share this news page